Adam H. Schechter
Also at Labcorp Holdings Inc
About
Adam H. Schechter is the President, Chief Executive Officer, and Chairman of the Board of Laboratory Corporation of America Holdings (LH). With an extensive background in the pharmaceutical and healthcare industries, he developed a reputation while serving at Merck & Co., Inc., where he led global operations as President of Global Human Health, Executive Vice President, and later as President of the Global Pharmaceutical Business.
After joining LH as a director on April 1, 2013, his leadership was further recognized when he was promoted to President and CEO on November 1, 2019. This marked a new phase in his career at LH, culminating with his appointment as Chairman of the Board on May 13, 2020, reflecting his strategic vision and operational expertise.
Under his guidance, LH has pursued significant growth initiatives, innovation in diagnostic testing, and strategic acquisitions and collaborations, all of which underscore his commitment to advancing healthcare outcomes and operational excellence.
At 59 years old as of 2024, his career is defined not only by his executive roles but also by his dedication to fostering excellence and integrity in both corporate and community engagements.